Human coronavirus 229E main protease (Mpro)

Human coronavirus 229E main protease (Mpro), also known as 3C-like protease (3CLpro) or nsp5, is a key enzyme essential for the replication of HCoV-229E, a common human respiratory pathogen [UniProt P0C6U2]. It is responsible for the post-translational processing of the large viral polyproteins, pp1a and pp1ab, at eleven specific sites to release functional non-structural proteins (nsps) that constitute the viral replication-transcription complex [Anand et al., Science, 2003]. Mpro is a homodimeric cysteine protease that specifically cleaves peptide bonds following a glutamine residue, a substrate specificity that is absent in human host cell proteases, making it an ideal target for highly selective antiviral therapy [PDB 1P9U]. Inhibition of Mpro effectively halts the viral life cycle by preventing the maturation of essential replication machinery. While HCoV-229E typically causes mild upper respiratory tract infections, its protease has served as a critical structural model for the development of broad-spectrum coronavirus inhibitors, including those targeting SARS-CoV and SARS-CoV-2 [Ziebuhr et al., J. Virol., 1995]. Drugs such as nirmatrelvir and experimental peptidomimetics like GC376 bind to the catalytic cysteine residue (Cys145 in HCoV-229E) to block enzymatic activity. Therapeutic challenges include the potential for emergent resistance mutations and the need for metabolic boosting in clinical applications.

Other names

3C-like protease3CLproNon-structural protein 5nsp5HCoV-229E MproC30 endopeptidase

Inhibition of the cysteine protease activity of nsp5, preventing the proteolytic cleavage of viral polyproteins pp1a and pp1ab into functional non-structural proteins required for the viral replication-transcription complex.